全文获取类型
收费全文 | 1167篇 |
免费 | 48篇 |
国内免费 | 67篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 37篇 |
妇产科学 | 24篇 |
基础医学 | 90篇 |
口腔科学 | 36篇 |
临床医学 | 198篇 |
内科学 | 184篇 |
皮肤病学 | 24篇 |
神经病学 | 39篇 |
特种医学 | 148篇 |
外科学 | 156篇 |
综合类 | 33篇 |
预防医学 | 153篇 |
眼科学 | 30篇 |
药学 | 99篇 |
肿瘤学 | 29篇 |
出版年
2021年 | 10篇 |
2020年 | 7篇 |
2018年 | 15篇 |
2016年 | 11篇 |
2015年 | 12篇 |
2014年 | 20篇 |
2013年 | 35篇 |
2012年 | 42篇 |
2011年 | 30篇 |
2010年 | 47篇 |
2009年 | 44篇 |
2008年 | 32篇 |
2007年 | 76篇 |
2006年 | 35篇 |
2005年 | 32篇 |
2004年 | 40篇 |
2003年 | 43篇 |
2002年 | 51篇 |
2001年 | 33篇 |
2000年 | 47篇 |
1999年 | 28篇 |
1998年 | 36篇 |
1997年 | 38篇 |
1996年 | 34篇 |
1995年 | 26篇 |
1994年 | 25篇 |
1993年 | 25篇 |
1992年 | 22篇 |
1991年 | 31篇 |
1990年 | 25篇 |
1989年 | 27篇 |
1988年 | 30篇 |
1987年 | 21篇 |
1986年 | 13篇 |
1985年 | 23篇 |
1984年 | 11篇 |
1983年 | 12篇 |
1982年 | 18篇 |
1981年 | 10篇 |
1980年 | 13篇 |
1979年 | 19篇 |
1978年 | 21篇 |
1977年 | 17篇 |
1976年 | 12篇 |
1975年 | 10篇 |
1973年 | 6篇 |
1972年 | 6篇 |
1971年 | 7篇 |
1970年 | 6篇 |
1966年 | 5篇 |
排序方式: 共有1282条查询结果,搜索用时 140 毫秒
61.
The seroepidemiology of rubella in western Europe 总被引:2,自引:0,他引:2
Pebody RG Edmunds WJ Conyn-van Spaendonck M Olin P Berbers G Rebiere I Lecoeur H Crovari P Davidkin I Gabutti G Gerike E Giordano C Hesketh L Plesner AM Raux M Rota MC Salmaso S Tischer A Valle M Miller E 《Epidemiology and infection》2000,125(2):347-357
Most of the countries in western Europe have now implemented mass infant rubella immunization programmes, instead of or in addition to selective vaccination in order to achieve the elimination of congenital rubella syndrome. The European countries Denmark, England and Wales, Finland, France, Germany, Italy and the Netherlands undertook large, national serological surveys collecting several thousand serum specimens during 1994-8. Antibodies against rubella virus were detected by a variety of enzyme immuno-assays. Comparability of the assay results was achieved by a standardized methodology. The age- and sex-stratified serological results were related to the schedules, coverage of rubella vaccination and the incidence in these countries. The results show widely differing levels of immunity to rubella both in the general population and in the specific age groups of males and females. A low rate (< 5%) of susceptibles in childhood and adolescents of both sexes was obtained only in Finland and the Netherlands. Countries such as Italy with only moderate coverage for the infant immunization programme currently have both high susceptibility levels in the general population and in the at-risk population. The likelihood is of continued epidemics of rubella with cases of congenital rubella syndrome. The continued implementation of selective vaccination will help to offset the impact of this ongoing transmission and to protect women on reaching childbearing age. 相似文献
62.
Beutels P Edmunds WJ Antoñanzas F De Wit GA Evans D Feilden R Fendrick AM Ginsberg GM Glick HA Mast E Péchevis M Van Doorslaer EK van Hout BA;Viral Hepatitis Prevention Board 《PharmacoEconomics》2002,20(1):1-7
The methods that have been used to estimate the clinical and economic impact of vaccination programmes are not always uniform, which makes it difficult to compare results between economic analyses. Furthermore, the relative efficiency of vaccination programmes can be sensitive to some of the more controversial aspects covered by general guidelines for the economic evaluation of healthcare programmes, such as discounting of health gains and the treatment of future unrelated costs. In view of this, we interpret some aspects of these guidelines with respect to vaccination and offer recommendations for future analyses. These recommendations include more transparency and validation, more careful choice of models (tailored to the infection and the target groups), more extensive sensitivity analyses, and for all economic evaluations (also nonvaccine related) to be in better accordance with general guidelines. We use these recommendations to interpret the evidence provided by economic evaluation applied to viral hepatitis vaccination. We conclude that universal hepatitis B vaccination (of neonates, infants or adolescents) seems to be the most optimal strategy worldwide, except in the few areas of very low endemicity, where the evidence to enable a choice between selective and universal vaccination remains inconclusive. While targeted hepatitis A vaccination seems economically unattractive, universal hepatitis A vaccination strategies have not yet been sufficiently investigated to draw general conclusions. 相似文献
63.
64.
Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox 总被引:4,自引:0,他引:4
We present data to confirm that exposure to varicella boosts immunity to herpes-zoster. We show that exposure to varicella is greater in adults living with children and that this exposure is highly protective against zoster (Incidence ratio=0.75, 95% CI, 0.63-0.89). The data is used to parameterise a mathematical model of varicella zoster virus (VZV) transmission that captures differences in exposure to varicella in adults living with and without children. Under the 'best-fit' model, exposure to varicella is estimated to boost cell-mediated immunity for an average of 20 years (95% CI, 7-41years). Mass varicella vaccination is expected to cause a major epidemic of herpes-zoster, affecting more than 50% of those aged 10-44 years at the introduction of vaccination. 相似文献
65.
66.
67.
Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation 总被引:8,自引:0,他引:8
BACKGROUND: There is increasing evidence that chronic atrial fibrillation (AF) is associated with a prothrombotic or hypercoagulable state. HYPOTHESIS: This study was undertaken to determine whether short-term exercise in patients with chronic AF would shift the overall hemostatic balance toward a more prothrombotic state with a reduction in fibrinolytic potential. METHODS: We recruited 20 patients (13 men; mean age 65 years +/- 11 standard deviation [SD]) with chronic AF who were not treated with antithrombotic therapy and exercised them to exhaustion using a multistage treadmill exercise (standard Bruce) protocol. Blood samples were taken pre exercise, immediately after cessation of exercise, and at 20 min post exercise. The prothrombotic state was quantified by fibrinogen (an index of hemorheology and a coagulation factor), soluble P-selectin (sP-sel, marking platelet activation), von Willebrand factor (vWF, an index of endothelial dysfunction), and plasminogen activator inhibitor-1 (PAI-1, a regulator of fibrinolytic activity) levels. There were two groups of age- and gender-matched controls in sinus rhythm: (1) healthy controls, and (2) "hospital controls" who were patients with vascular disease. RESULTS: Baseline levels of vWf (p = 0.034) and fibrinogen (p < 0.0001), but not sP-sel (p = 0.075) were significantly elevated in patients with AF compared with both control groups in sinus rhythm. The PAI-1 levels were highest in the hospital control patients, but not in chronic AF (p = 0.041). Following treadmill exercise, achieving a mean metabolic equivalent of 4.9 METS (+/- 1.75 SD) and total exercise duration of 4.9 min (+/- 2 SD), there was a significant rise in plasma fibrinogen (repeated measures analysis of variance [ANOVA] p = 0.047) and a reduction in PAI-1 levels (p = 0.025) in patients with AF. There were no significant changes seen in vWf (p = 0.308) or sP-sel (p = 0.071) levels. No significant changes in these indices were seen in hospital controls (all p = not significant), despite a much longer duration of exercise with greater workload. CONCLUSION: Patients with chronic AF have increased vWf and fibrinogen levels compared with sinus rhythm. Exercise to exhaustion influences the hypercoagulable state in chronic AF, with a rise in plasma fibrinogen and possible increase in fibrinolytic activity. Nevertheless, acute exercise does not appear to have a significant influence on endothelial dysfunction or platelet activation in patients with AF. 相似文献
68.
69.
70.
Despite national guidelines for treatment of hyperlipidemia, significant numbers of individuals with coronary artery disease are not treated to their National Cholesterol Education Program (NCEP) low-density lipoprotein (LDL) goals. The potential benefits of a clinical pharmacist-managed lipid clinic would be to improve rates of success in achieving these goals, improve drug adherence and compliance with therapy, and reduce cardiovascular events. All patients who had a documented history of coronary artery disease and were under the care of one cardiologist were treated in the pharmacist-managed lipid clinic. A second cardiologist provided usual care to a group of patients with coronary artery disease who served as controls. Patients in each arm were followed for a minimum of 6 months. A protocol for therapy changes in clinic patients was developed by the clinical pharmacist and approved by the cardiologist. At the end of 6 months, 69% of patients in the pharmacist-managed clinic achieved their LDL goal, compared with 50% of controls. Compliance with laboratory tests and drug regimens also improved in clinic patients. Compliance with lipid panels went from 8% 2 months before to 89% 2 months after the start of the study. At the end of 6 months compliance with laboratory work and refills was 80%. Thus the clinical pharmacist-managed clinic was highly successful in achieving NCEP goals for secondary prevention. 相似文献